TIFFANY MCKIRNAN: Open Payments
NPI 1568659118 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$630 in 33 payments from 15 companies in 2025. Trend: 2023 $413 · 2024 $371 · 2025 $630
Food & beverage: $630
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 13 | $201 |
| Endo USA, Inc. | 3 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $46 |
| IMMUNITYBIO, INC. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $35 |
| ABBVIE INC. | 1 | $32 |
| Dendreon Pharmaceuticals LLC | 1 | $31 |
| UROGEN PHARMA, INC. | 1 | $23 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $21 |
Products named: ORGOVYX, AVEED, Nubeqa, PYLARIFY, ANKTIVA, GEMTESA, Xtandi, BOTOX.
Industry payments across OH — which companies pay providers there.
